Skip to main content
SpringerLink
Log in

Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Purpose

Obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) have been known to be associated with atherosclerosis and hypoxia which was suggested to have an important role in this process by the way of increased oxidative stress. In the present study, we aimed to evaluate the effects of nocturnal hypoxia pattern (intermittent versus sustained) on serum lipid peroxidation and paraoxonase (PON) activity.

Methods

Blood collections were performed in 44 OSA, 11 non-apneic, nocturnal desaturated COPD, and 14 simple snorer patients after full-night polysomnographic recordings. Nocturnal sleep and respiratory parameters, oxygen desaturation indexes, serum malondialdehyde (MDA) levels by measuring with the help of the formation of thiobarbituric acid reactive substances (TBARS), and PON activity were assessed in all subjects.

Results

OSA and COPD patients showed nocturnal hypoxemia, with a minimum oxygen saturation (SaO2) in ranges of 53–92 % and 50–87 %, respectively. The mean levels of TBARS was 15.7 ± 3.6 nmol and 15.3 ± 3.4 nmol malondialdehyde (MDA)/ml in OSA and COPD patients, respectively, while the mean level of the control group was 4.1 ± 1.2 nmol MDA/ml. The mean PON activity was found to be 124.2 ± 35.5 U/l in OSA patients and 124.6 ± 28.4 U/l in COPD patients. The mean PON activity of the control group was 269.0 ± 135.8 U/l. The increase in TBARS levels and the decrease in PON1 levels were statistically significant in both OSA and COPD patients according to controls (p < 0.001 for TBARS as well as PON1).

Conclusion

The results of this study revealed that both OSA and non-apneic, nocturnal desaturated COPD patients showed increased levels of lipid peroxidation and decreased PON activity despite the differences in nocturnal hypoxia pattern.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, Bende M (1999) An independent association between obstructive sleep apnoea and coronary artery disease. Eur Res J 14:179–184

    Article  CAS  Google Scholar 

  2. Yaggi H, Mohsenin V (2003) Sleep-disordered breathing and stroke. Clin Chest Med 24:223–237

    Article  PubMed  Google Scholar 

  3. Camilli AG, Robbins DR, Lebowitz MD (1991) Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 133:795–800

    PubMed  CAS  Google Scholar 

  4. MacNee W, Maclay J, McAllister D (2008) Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:824–833

    Article  PubMed  CAS  Google Scholar 

  5. Kluchova Z, Perrasova P, Joppa DZ, Tkacova R (2007) The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 56:51–56

    PubMed  CAS  Google Scholar 

  6. Coulson JM, Rudd JHF, Duckers JM, Rees JLS, Shale DJ, Bolton CE, Cockcroft JR (2010) Excessive aortic inflammation in chronic obstructive pulmonary disease: an 18 F-FDG PET pilot study. J Nucl Med 51:1357–1360

    Article  PubMed  Google Scholar 

  7. Lavie P, Lavie L (2008) Cardiovascular morbidity and mortality in obstructive sleep apnea. Curr Pharmaceut Des 14:3466–3473

    Article  CAS  Google Scholar 

  8. Fletcher EC, Miller J, Divine GW, Fletcher RN, Miller T (1987) Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tension above 60 mmHg. Chest 92:604–608

    Article  PubMed  CAS  Google Scholar 

  9. Fletcher EC, Luckett RA, Goodnight-White S, Miller CC, Qian W, Costarangoz-Galarza C (1992) A double blind trial of nocturnal supplement oxygen for sleep desaturation in patient with chronic obstructive pulmonary disease and a daytime PaO2 >60 mmHg. Am Rev Respir Dis 145:1070–1076

    Article  PubMed  CAS  Google Scholar 

  10. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M (2000) Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118:656–664

    Article  PubMed  Google Scholar 

  11. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313:711–715

    Article  PubMed  CAS  Google Scholar 

  12. Mackness MI, Durrington PN, Mackness B (2004) The role of paraoxonase 1 activity in cardiovascular disease. Am J Cardiovasc Drugs 4(4):211–217

    Article  PubMed  CAS  Google Scholar 

  13. Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27:123–128

    PubMed  Google Scholar 

  14. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H (2005) Oxidative stress in obstructive sleep apnea. Chest 127:1674–1679

    Article  PubMed  CAS  Google Scholar 

  15. Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, Q’Donnell CP, Adachi M (2006) Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J 28:378–385

    Article  PubMed  CAS  Google Scholar 

  16. MacNee W (2000) Oxidants/antioxidants and COPD. Chest 117:303–317

    Article  Google Scholar 

  17. Chess PR, O'Reilly MA, Sachs F, Finkelstein JN (2005) Reactive oxidant and p42/44MAP kinase signaling is necessary for mechanical strain-induced proliferation in pulmonary epithelial cells. J Appl Physiol 99(3):1226–1232

    Article  PubMed  CAS  Google Scholar 

  18. Papaiahgari S, Yerrapureddy A, Hassoun PM, Garcia JG, Birukov KG, Reddy SP (2007) EGFR-activated signaling and actin remodeling regulate cyclic stretch-induced NRF2-ARE activation. Am Respir Cell Mol Biol 36(3):304–312

    Article  CAS  Google Scholar 

  19. McQuaid KE, Smyth EM, Keenan AK (1996) Evidence for modulation of hydrogen peroxide induced endothelial barrier dysfunction by nitric oxide in vitro. Eur J Pharmacol 307(2):233–241

    Article  PubMed  CAS  Google Scholar 

  20. McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159–63

    Article  PubMed  CAS  Google Scholar 

  21. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M (2000) Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 118:656–664

    Article  PubMed  Google Scholar 

  22. Friedman GD, Klatsky AL (1976) Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 294:1071–1075

    Article  PubMed  CAS  Google Scholar 

  23. Johns MW (1992) Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15(4):376–381

    PubMed  CAS  Google Scholar 

  24. Pauwels RA, Buıst AS, Calverley PMA (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163:1256–1276

    PubMed  CAS  Google Scholar 

  25. Iber K, Ancoli-Israel S, Chesson AL, Quan SF (2007) The AASM manual for the scoring of sleep and associated events. American Academy of Sleep Medicine, Westchester

    Google Scholar 

  26. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN (1991) Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 86:193–199

    Article  PubMed  CAS  Google Scholar 

  27. Yagi K (1984) Assay for blood plasma or serum. Methods Enzymol 105:328–31

    Article  PubMed  CAS  Google Scholar 

  28. Halliwell B, Chirico S (1993) Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 57:715–725

    Google Scholar 

  29. Alzoghaibi MA, BaHammam AS (2011) The effect of night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea. Sleep Breath;doi 10.1007/s11325-011-0531-z.

  30. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R (2008) Effects of continuous positive airway pressure on cardiovascular risk profile in patients whit severe obstructive sleep apnea and metabolic syndrome. Chest 134:686–692

    Article  PubMed  CAS  Google Scholar 

  31. Vatansever E, Surmen-Gur E, Ursavaş A, Karadağ M (2011) Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath 15:275–282

    Article  PubMed  Google Scholar 

  32. Rahman I, Skwarska E, MacNee W (1997) Attenuation of oxidant/antioxidant imbalance during treatment of exacerbation of chronic obstructive pulmonary disease. Thorax 52:565–568

    Article  PubMed  CAS  Google Scholar 

  33. Stanojkovic I, Kotur-Stevuljevic J, Milenkovic B, Spasic S, Vujic T, Stefanovic A, Ilic A, Ivanisevic J (2011) Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation. Respir Med 105:31–37

    Article  Google Scholar 

  34. Aviram M (1996) Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis and the antiatherogenicity of antioxidant. Eur J Clin Chem Clin Biochem 34:599–608

    PubMed  CAS  Google Scholar 

  35. Steinberg DS, Parthasarathy TE, Carew JC Khoo, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924

    Article  PubMed  CAS  Google Scholar 

  36. Aviram M (1993) Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 98:1–9

    Article  PubMed  CAS  Google Scholar 

  37. Mitchinson MJ, Ball RY, Carpenter KL, Enright JH (1990) Macrophages and ceroid in human atherosclerosis. Eur Heart J 11:116–121

    Article  PubMed  CAS  Google Scholar 

  38. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. J Clin Invest 101(8):1581–1590

    Article  PubMed  CAS  Google Scholar 

  39. Leuenberger UA, Hogeman CS, Quraishi S, Linton-Frazier L, Gray KS (2007) Short-term intermittent hypoxia enhances sympathetic responses to continuous hypoxia in humans. J Appl Physiol 103:835–842

    Article  PubMed  Google Scholar 

  40. Gilmartin GS, Lynch M, Tamisier R, Weiss JW (2010) Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol 299:925–931

    Article  Google Scholar 

  41. Tamisier R, Gilmartin GS, Launois SH, Pepin JL, Nespoulet H, Thomas R, Levy P, Weiss JW (2009) A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure. J Appl Physiol 107:17–24

    Article  PubMed  CAS  Google Scholar 

  42. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG (1996) Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 97:1916–1923

    Article  PubMed  CAS  Google Scholar 

  43. Inoue N, Kawashima S, Hirata KI, Rikitake Y, Takeshita S, Yamochi W, Akita H, Yokoyama M (1998) Stretch force on vascular smooth muscle cells enhances oxidation of LDL via superoxide production. Am J Physiol 274:1928–1932

    Google Scholar 

  44. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88:4673–4676

    Article  PubMed  CAS  Google Scholar 

  45. Suzuki K, Ito Y, Ochiai J, Kusuhara Y, Hashimoto S, Tokudome S, Kojima M, Wakai K, Toyoshima H, Tamakoshi K, Watanabe Y, Hayakawa N, Maruta M, Watanabe M, Kato K, Ohta Y, Tamakoshi A (2003) JACC Study Group. Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac J Cancer Prev 4:259–266

    PubMed  Google Scholar 

  46. Harman SM, Liang L, Tsitouras PD, Gucciardo F, Heward CB, Reaven PD, Ping W, Ahmed A, Cutler RG (2003) Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2) measured by liquid chromatography–mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med 35:1301–1309

    Article  PubMed  CAS  Google Scholar 

  47. Kirkham PA, Spooner G, Ffoulkes-Jones C, Calvez R (2003) Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. Free Radic Biol Med 35:697–710

    Article  PubMed  CAS  Google Scholar 

  48. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546–2551

    Article  PubMed  CAS  Google Scholar 

  49. Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF (1997) High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25–28

    Article  PubMed  CAS  Google Scholar 

  50. Kashiwagi A, Shinozaki K, Nishio Y, Maegawa H, Maeno Y, Kanazawa A, Kojima H, Haneda M, Hikada H, Yasuda H, Kikkawa R (1999) Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol 277:976–983

    Google Scholar 

  51. Tekes S, Isik B, Yildiz T, Simsek S, Isik MR, Budak T (2010) Chronic obstructive pulmonary disease and paraoxonase 1 192 and 55 gene polymorphisms. Biotechnology & Biotechnological Equipment 24(1):1644–1647

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sleep Disorders Unit, Sureyyapasa Chest Disease Training and Research Hospital, Istanbul, Turkey

    Hacer Kuzu Okur

  2. Vocational School of Health Related Professions, Gazikent University, Gaziantep, Turkey

    Zerrin Pelin

  3. Vocational School of Health Related Professions, Department of Medical Laboratory, Marmara University, Istanbul, Turkey

    Meral Yuksel

  4. Meram Medical Faculty, Department of Chest Disease, Selcuk University, Konya, Turkey

    Sebnem Yosunkaya

  5. Mehmet Sengün Sok. Celiker Apt: 6/19, Fenerbahce, Istanbul, Turkey

    Hacer Kuzu Okur

Authors
  1. Hacer Kuzu Okur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zerrin Pelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Meral Yuksel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sebnem Yosunkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hacer Kuzu Okur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okur, H.K., Pelin, Z., Yuksel, M. et al. Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia. Sleep Breath 17, 365–371 (2013). https://doi.org/10.1007/s11325-012-0703-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-012-0703-5

Keywords

Search

Navigation